๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I study of the distamycin derivative FCE 24517

โœ Scribed by Armand, JP; Abigerges, D; Da Costa, L; Fadel, E; Mignard, D; Lhomme, C; Zurlo, MG; Gandia, D


Book ID
123448620
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
143 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Establishment of l1210 leukemia cells re
โœ Cristina Geroni; Enrico Pesenti; Giovanna Tagliabue; Dario Ballinari; Nicola Mon ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 723 KB

N-deformyl-N-~4-N,N-bis(2-chloroethylam~no)benzoyl] distamycin-A (FCE 24517) is a new cytotoxic anti-tumor agent in phase-I clinical trials. We have isolated stable FCE-245 17resistant cell sublines from murine leukemia LIZ10 cells by in vitro exposure to the drug. FCE 245 I 7 selects a mixed popula

Phase I study of Y-20024 (new benzamide
โœ T. Kawaguchi; M. Murasaki; A. Sumiyoshi; M. Uchiumi; J. Ishigouoka; M. Kobayashi ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 217 KB